Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Karas currently holds 519,588 shares of ARS Pharmaceuticals, Inc. (SPRY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Karas has been a net seller of SPRY stock. They have purchased $0 and sold $530.0K worth of shares.
Eric Karas's most recent insider trade was on Jun 12, 2026, when they sold 25,000 shares at $0.00 per share.
Eric Karas serves as Executive at ARS Pharmaceuticals, Inc. (SPRY). They have executed 12 insider transactions totaling $530.0K over their tenure at the company.
Eric Karas holds the position of Executive at ARS Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Eric Karas has shown a selling trading pattern, with $0 in total purchases and $530.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric Karas was on Jun 12, 2026, when they sold $250.0K worth of SPRY shares. This transaction involved 25,000 shares at $10.00 per share.
Eric Karas currently owns 519,588 shares of ARS Pharmaceuticals, Inc. (SPRY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Karas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Karas has 12 Form 4 filings on record as an insider at ARS Pharmaceuticals, Inc..
Set alerts for Eric Karas and 40,000+ other insiders.